Schedule 13D ownership disclosure

Whitehawk Therapeutics, Inc.

Security class unavailable · CUSIP: 00032Q104

Event date: 2021-08-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,529,402
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-113485
Form type
SC 13D
Filer
ACUTA CAPITAL PARTNERS, LLC
CIK
CIK 1582844
Filed
Sep 07, 2021
Reporting period
Aug 26, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub